M. Hylkema (Groningen, The Netherlands), J. C. Virchow (Rostock, Germany)
Soluble CD14 (sCD14) 18, 42 and 162 hours after segmental allergen challenge in atopic asthmatics
P. Julius, C. Grosse-Thie, K. Michael, B. Kai, F. Sebastian, W. Luttmann, J. C. Virchow (Rostock, Germany)
|  |
Altered expression of inflammatory markers in blood in pig farmers
K. Sahlander, K. Larsson, L. Palmberg (Stockholm, Sweden)
| |
Interleukin 10 regulates airway remodeling through the TGF-β signaling
N. Fueki, H. Sagara, M. Ota, K. Akimoto, T. Okada, K. Sugiyama, M. Fueki, S. Makino, T. Fukuda (Simotsuga-gun, Maebashi, Japan)
| |
Deficiency of tenascin C attenuates airway hyperresponsiveness in an experimental model of bronchial asthma
H. Nakahara, E. C. Gabazza, Y. Nishii, H. Fujimoto, H. Kobayashi, C. N. D‘Alessandro-Gabazza, H. Yasui, O. Taguchi (Tsu, Japan)
| |
Influence of house dust mite Der p antigen on expression of monocyte chemoattractant protein-1(MCP-1) in bronchial epithelial cells
B. Sun, A. Wu, N. Zhong (Guangzhou, China; Hong Kong, Hong Kong)
| |
IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM)
H. Chanteux, C. Pilette, A. Guisset, Y. Sibille (Brussels, Belgium)
| |
Suppression of basophil activation via histamine receptor 2 (HR2)
N. Mete, M. Akdis, J. Zumkehr, C. Akdis (Davos, Switzerland; Izmir, Turkey)
| |
Serum level of tryptase in atopic and non-atopic asthmatics
M. Przybyszewski, A. Dziedziczko, M. Zbikowska-Gotz (Bydgoszcz, Poland)
| |
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
G. Ilonidis, G. Anogianakis, I. Giavazis, E. Theofilogiannakos, A. Anogeianaki, P. Glouftsios (Thessaloniki, Greece)
| |
Cytokines, bone markers and weight in patients with advanced pulmonary disease
L. Førli, O. J. Mellbye, E. Haug, O. Bjørtuft, M. Vatn, J. Kofstad, J. Boe (Oslo, Norway)
| |
Asthma with fixed airways obstruction is characterised by increased airway endotoxin, IL-8 and OSM
J. L. Simpson, J. Douwes, T. V. Grissell, P. G. Gibson (Newcastle, Australia; Wellington, New Zealand)
| |
Levels of immunoglobulins of classes A and G in saliva in patients with COPD
L. A. Stepanishcheva, S. N. Teplova, E. A. Chuhareva, T. V. Alechina, D. G. Zarcova (Chelyabinsk, Russian Federation)
| |
Interrelation risk factors and spirography data with humoral immunity parameters during COPD exacerbation
G. V. Ashyrov, J. A. Mikryukova, G. L. Ignatova, E. V. Sheklanova (Chelyabinsk, Russian Federation)
| |
Inflammatory effects of air pollution exposure on a murine model of chronic asthma
D. Carnieli, E. Yoshioka, F. Arantes, D. Kasahara, T. Mauad, M. Dolhnikoff, T. Lanças, M. Morales, P. Saldiva, M. Martins (Sao Paulo, Brazil)
| |
Early Ascaris suum migration in mice induces eosinophils airway inflammation and hyperresponsiveness
A. Perini, C. S. Enobi, M. L. B. Garcia, M. A. Martins, M. F. M. Soares (Sao Paulo, Brazil)
| |
Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma
B. Fuchs, V. J. Erpenbeck, J. M. Hohlfeld, N. Krug, A. Braun (Hannover, Germany)
| |
Single versus multiple challenge in a mouse model of chemical-induced asthma
J. A. Vanoirbeek, M. Tarkowski, P. H. Hoet, N. Ben (Leuven, Belgium; Lodz, Poland)
| |
Effect of Angiostrongylus costaricensis extract on eosinophilic pulmonary response in BALB/c mice
P. M. Pitrez, L. A. Pinto, A. C. Dias, B. L. Rymer, F. M. Martins, M. H. Jones, C. G. Teixeira, D. C. Machado, R. T. Stein (Porto Alegre, Brazil)
| |
Establishment of an experimental BALB/c mouse model for studies on isocyanate asthma
L. Z. Sun, S. Elsayed, A. Irgens, N. P. Aardal, T. B. Aasen (Bergen, Norway)
| |
Study of role of insulin and insulin receptor in allergic airway inflammation of rats
Y. Ma, Q. He (Beijing, China)
| |